1. Home
  2. AENT vs LUNG Comparison

AENT vs LUNG Comparison

Compare AENT & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alliance Entertainment Holding Corporation

AENT

Alliance Entertainment Holding Corporation

HOLD

Current Price

$7.73

Market Cap

358.7M

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$2.59

Market Cap

63.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AENT
LUNG
Founded
1990
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Durable Goods
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
358.7M
63.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AENT
LUNG
Price
$7.73
$2.59
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$10.00
$6.81
AVG Volume (30 Days)
57.8K
1.0M
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
131.70
N/A
EPS
0.38
N/A
Revenue
$1,088,441,000.00
$91,664,000.00
Revenue This Year
$7.29
$9.21
Revenue Next Year
$1.84
$5.03
P/E Ratio
$19.98
N/A
Revenue Growth
N/A
15.59
52 Week Low
$2.21
$1.31
52 Week High
$11.57
$9.37

Technical Indicators

Market Signals
Indicator
AENT
LUNG
Relative Strength Index (RSI) 60.10 69.75
Support Level $7.07 $2.43
Resistance Level $8.00 $2.65
Average True Range (ATR) 0.54 0.21
MACD 0.03 0.05
Stochastic Oscillator 65.38 92.13

Price Performance

Historical Comparison
AENT
LUNG

About AENT Alliance Entertainment Holding Corporation

Alliance Entertainment Holding Corp is a distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world. The company has two divisions: Alliance Home Entertainment, which offers full-service support across production, marketing, and retail execution. and Alliance Authentic, which focuses on licensed collectibles and branded merchandise, including partnerships with Handmade by Robots, Master Replicas, and Weta Workshop.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: